Nucleoside/nucleotide reverse transcriptase inhibitor-associated weight gain in people living with HIV
Data from the Copenhagen Comorbidity in HIV Infection (Cocomo) study
Bibliographic Data
Weight gain effects of Nucleoside/Nucleotide Reverse Transcriptase Inhibitors in people with HIV (PWH) have been sparsely studied.Participants were enrolled in the Copenhagen Comorbidity in HIV Infection (COCOMO) study. PWH receiving a backbone of emtricitabine, or lamivudine combined with abacavir, tenofovir disoproxil, or tenofovir alafenamide were analysed. Weight gain according to ART backbone and to the third drug was analysed using a multiple linear regression model. Non-ART risk factors were also determined using multiple linear regression.A total of 591 participants were included in the analysis. The majority were middle-aged, virally suppressed males with a mean BMI just above the normal range. Both tenofovir disoproxil/emtricitabine or lamivudine and abacavir /emtricitabine or lamivudine, but not tenofovir alafenamide /emtricitabine or lamivudine were associated with weight gain over two years (0.6 kg, p = 0.025; 1.0 kg, p = 0.005). The third drugs associated with weight increase were non-nucleoside reverse transcriptase inhibitors (NNRTI) (p = 0.035), dolutegravir (p = 0.008) and atazanavir (p = 0.040). Non-ART risk factors for gaining weight were low or normal BMI, age <40 years, underweight, inactivity or highly active at baseline.Tenofovir disoproxil and abacavir-based ART regimens were associated with a small weight gain. Third drug NNRTI, dolutegravir and atazanavir were associated with an increase in weight
Antiretroviral therapy · Biology · Comorbidity · Gene · Nucleoside · Nucleoside Reverse Transcriptase Inhibitor · Polymerase chain reaction · Reverse transcriptase · Reverse-transcriptase inhibitor · Viral load · HIV-related health complications and treatments · Medicine · Nutrition and Health in Aging · Obesity and Health Practices · Genetics · Internal Medicine · Virology
Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
Body-mass index and all-cause mortality
Association of All-Cause Mortality With Overweight and Obesity Using Standard Body Mass Index Categories
Body mass index and quality of life in people living with HIV
Dietary intake and overweight and obesity among persons living with HIV in Atlanta Georgia
Obesity Stigma
| Citation velocity | historical |
|---|---|
| Highly cited | No |